期刊文献+

伴BCL2/IGH融合基因的急性淋巴细胞白血病二例并文献复习

Acute lymphoblastic leukemia with BCL2/IGH fusion gene: report of two cases and review of literature
原文传递
导出
摘要 目的探讨伴BCL2/IGH融合基因急性淋巴细胞白血病(ALL)患者的临床特征、疗效及预后。方法分析2例罕见伴t(14;18)易位的ALL患者临床和实验室特征,并进行文献复习。结果结合骨髓细胞形态学和流式细胞免疫分型技术诊断2例急性前体B细胞性淋巴细胞白血病患者,骨髓细胞核型分析显示伴有t(14;18)染色体易位;BCL2/IGH融合探针丝裂间期及中期荧光原位杂交(FISH)检测到BCL2/IGH融合信号;聚合酶链反应(PCR)检测出其中1例同时伴有MLL-AF4融合基因。结论伴BCL2/IGH融合基因的ALL较为罕见,次级染色体异常对其预后及生存期可能均有影响,还需更多病例明确骨髓干细胞移植是否能延长其生存期。
作者 郭孟乔 唐古生 王健民 张春玲 程辉 龚胜蓝 杨建民 Guo Mengqiao;Tang Gusheng;Wang Jianmin;Zhang Chunling;Cheng Hui;Gong Shenglan;Yang Jioamin(Department of ttematology,Changhai Hospital,the Second Military Medical University,Shanghai 200433,China)
出处 《白血病.淋巴瘤》 CAS 2018年第9期550-554,共5页 Journal of Leukemia & Lymphoma
基金 国家自然科学基金青年基金(81200383)
  • 相关文献

参考文献2

二级参考文献15

  • 1Sirulnik LA, Stone RM. Acute promyelocytic leukemia: current strategies for the treatment of newly diagnosed disease. Clin Adv Hematol Oncol, 2005, 5: 391-397.
  • 2Rohr SS, Pelloso LA, Borgo A, et al. Acute promyelocytic leukemia associated with the PLZF-RARA fusion gene: two additional cases with clinical and laboratorial peculiar presentations. Med Oncol, 2012, 29: 2345-2347.
  • 3Hong SD, Kim YK, Kim HN, et al. Treatment outcome of all-trans retinoic acid/anthracycliue combination chemotherapy and the prognostic impact of FLT3/ITD mutation in acute promyelocytic leukemia patients. Korean J Hematol, 2011, 46: 24-30.
  • 4Greenwood M J, Seftel MD, Richardson C, et al. Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. Leuk Lymphoma, 2006, 47: 1245-1252.
  • 5Licht JD, Chomienne C, Goy A, et al. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia ass~iated with translocation (11 ;17). Blood, 1995, 85: 1083-1094.
  • 6Petrie K, Zelent A, Waxman S. Differentiation therapy of acute myeloid leukemia: past, present and future. Curr Opin Hematol, 2009, 16: 84-91.
  • 7Liu Y J, Wu DP, Liang JY, et al. Long-term surveyofoutcome in acute promyelocyfic leukemia:a single center experience in 340 patients. Med Oncol, 2010, 1: 323-332.
  • 8Bassi SC, Rego EM. Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia. Rev Bras Hematol Hemoter, 2012, 34: 134-139.
  • 9Sanz MA, Grimwade D, Tallman MS, et al.Management of acute promyelo-cytic leukemia: recommendations from an expert panel on behalf of the European Leukemia Net. Blood, 2009, 113:1875-1891.
  • 10Wells RA, Catzavelos C, Kamel-Reid S. Fusion of retinoic acid receptor a to NuMA, the nuclear mitotic apparatus protein, by a variant translocatian in acute promyelocytic leukaemia. Nat Genet, 1997, 17: 109-113.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部